Hospice Care in Corona, CA
5 Hospice found. Showing 1 - 5
 Southern California Home Health And Hospice Medicare Approved Location: 730 Magnolia Avenue, Corona, California 92879 Phone: (951) 736-7200 |
Family Hospice Care Inc Medicare Approved Location: 255 E Rincon Street, Suite #315-a, Corona, California 92879 Phone: (951) 231-2186 |
Holistic Care Hospice Medicare Approved Location: 4740 Green River Road Ste 318, Corona, California 92880 Phone: (951) 734-1300 |
Inland Regional Hospice Medicare Approved Location: 1128 East 6th Street, Suite #5, Corona, California 92879 Phone: (909) 213-1000 |
Always Tfy Hospice, Inc Medicare Approved Location: 4740 Green River Road, Corona, California 92880 Phone: (951) 271-9742 |
News Archive
Study reveals functional dynamics of ion channels
Most ion channels are very selective about the ions, which may or may not pass through them. They may be conductive for potassium ions and non-conductive for sodium ions or vice versa.
Air pollution can cause neurological damage
Researchers looking at the brainstems of children and young adults exposed lifelong to air pollution in Mexico City have discovered disturbing evidence of harm.
Study: People who get occasional migraines are more likely to be obese
People who get occasional migraines are more likely to be obese than people who do not have migraines, according to a study published in the September 11, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
UCSD scientists discover steroid hormone that inhibits brain inflammation
Researchers at the University of California, San Diego School of Medicine have discovered a steroid hormone that inhibits inflammation in the brain. The findings, to be published in the May 13 issue of the journal Cell, have implications for understanding the exaggerated inflammatory responses that are characteristic features of numerous neurodegenerative diseases.
Progesterone vaginal gel 8% NDA transferred to Watson
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has transferred the new drug application for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy (NDA 22-139) to Watson.
› Verified 8 days ago